ProPhase Labs, Inc. (Formerly Known as Quigley Corporation)

121 articles about ProPhase Labs, Inc. (Formerly Known as Quigley Corporation)

• ProPhase Labs to Present at the H.C. Wainwright 24th Annual Global Investment Conference September 12-14, 2022 (HYBRID CONFERENCE)

  9/6/2022

  ProPhase Labs, Inc. (NASDAQ: PRPH), a growth oriented and diversified diagnostics, genomics and biotech company, today announced it will be featured as a presenting company at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022 at 2:30 pm, Eastern Time.

• ProPhase Labs Announces Record Second Quarter 2022 Financial Results

  8/11/2022

  ProPhase Labs, Inc. today reported its financial and operational results for the second quarter ended June 30, 2022.

• ProPhase Labs to Host Second Quarter 2022 Financial Results Conference Call on Thursday, August 11, 2022 at 11:00 a.m. Eastern Time

  8/5/2022

  ProPhase Labs, Inc., a growth oriented and diversified diagnostics, genomics and biotech company, will hold a conference call on Thursday, August 11, 2022 at 11:00 a.m. Eastern time to discuss its results for the second quarter ended June 30,2022.

• ProPhase Labs Announces New $6 Million Stock Repurchase Plan

  7/26/2022

  ProPhase Labs, Inc. (NASDAQ: PRPH), a rapidly growing and diversified diagnostics, genomics and biotech company, today announced that its Board of Directors has authorized a stock repurchase program of up to $6 million in ProPhase Labs’ common stock.

• ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology

  6/28/2022

  Company Also Announces First Licensing Agreement for PBIO with Global BioLife, Inc. for broad based Anti-Viral Fighting Compounds.

• ProPhase Labs Announces Record Financial Results for the Fourth Quarter and Full Year Ended December 31, 2021

  3/30/2022

  ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified diagnostics and genomics company, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2021.

• ProPhase Labs Announces Special Cash Dividend - Feb 16, 2022

  2/16/2022

  ProPhase Labs, Inc., a diversified biotech and genomics company, announced that its Board of Directors has declared a special cash dividend in the amount of $0.30 per share on its common stock, payable on March 10, 2022 to stockholders of record as of March 1, 2022.

• Kennedy Capital Advises ProPhase Labs Inc. in the Acquisition of a New Jersey Laboratory

  11/6/2020

  ProPhase Labs Inc. has acquired a New Jersey laboratory owned by Confucius Plaza Medical Laboratory. Kennedy Capital served as the exclusive brokerage to the transaction. The lab, which is approved for a variety of medical tests, including Covid-19 and respiratory pathogen panel molecular tests, will be owned by the company'

• ProPhase Labs Announces Preliminary Results of its Tender Offer

  12/20/2017

  ProPhase Labs announced today the preliminary results of its tender offer to purchase up to 1,700,000 shares of its common stock at a price of $2.30 per share, which expired at midnight, New York City time, on December 18, 2017.

• ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2017

  11/13/2017

  Net sales from continuing operations were $5.7 million for the nine months ended September 30, 2017, as compared to net sales of $3.4 million for the nine months ended September 30, 2016.

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) Announces Final Results Of Its Tender Offer

  9/29/2017

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) Reports Financial Results For The Three Months And Six Months Ended June 30, 2017

  8/11/2017

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) Discusses The Current Cold Season And Announces Launch Of New Product Line, TK Supplements

  1/14/2016

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) Reports Financial Results For The Three And Nine Months Ended September 30, 2015

  11/13/2015

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) Reports Financial Results For The Three And Six Months Ended June 30, 2015

  8/13/2015

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) Establishes 3.2 Million Share Equity Line

  8/6/2015

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) Reports Financial Results For The Three Months Ended March 31, 2015

  5/14/2015

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) Reports Financial Results For The Fourth Quarter And Year Ended December 31, 2014

  3/30/2015

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) CEO & Chairman Ted William Karkus To Be Interviewed On Clear Channel - iHeart Business Talk Radio's "The Trader's Network" On December 11, 2014

  12/12/2014

• ProPhase Labs, Inc. (Formerly Known as Quigley Corporation) Reports Financial Results For The Three And Nine Months Ended September 30, 2014

  11/14/2014